Literature DB >> 27630750

Pregnancy and lactation advice: How does Australian Product Information compare with established information resources?

Emma Brown1, Elizabeth Hotham2, Neil Hotham3.   

Abstract

BACKGROUND: Product information is a popular medicines information resource; however, there is some evidence that its pregnancy and lactation information is overconservative, which can lead to inadequate treatment of pregnant and lactating women.
METHODS: A thorough analysis of pregnancy and lactation information within Australian Product Information and Consumer Medicines Information was performed. The statements within these resources were compared with established clinical resources: Australian Medicines Handbook, Therapeutic Guidelines, South Australian Perinatal Practice Guidelines, Organization of Teratology Information Specialists, LactMed, Motherisk and the Pregnancy and Breastfeeding Medicines Guide published by the Royal Women's Hospital Melbourne.
RESULTS: Product Information was found to be the most cautious resource, with 44.5% of pregnancy recommendations and 69% of lactation recommendations reviewed being more conservative than other resources.
CONCLUSION: Product Information is an imperfect and often overconservative reference for pregnant and lactating women. Health professionals are urged to review established clinical resources to inform decision making.

Entities:  

Keywords:  Drugs (medication); clinical pharmacology; maternal–fetal medicine

Year:  2016        PMID: 27630750      PMCID: PMC5010117          DOI: 10.1177/1753495X16637750

Source DB:  PubMed          Journal:  Obstet Med        ISSN: 1753-495X


  20 in total

Review 1.  Drug therapy for breast-feeding women.

Authors:  S Ito
Journal:  N Engl J Med       Date:  2000-07-13       Impact factor: 91.245

2.  Evidence based information on drug use during pregnancy: a survey of community pharmacists in three countries.

Authors:  D A Lyszkiewicz; S Gerichhausen; I Björnsdóttir; T R Einarson; G Koren; A Einarson
Journal:  Pharm World Sci       Date:  2001-04

3.  Toward improved pregnancy labelling.

Authors:  Gideon Koren; Sachi Sakaguchi; Chagit Klieger; Alex Kazmin; Alla Osadchy; Parvaneh Yazdani-Brojeni; Ilan Matok
Journal:  J Popul Ther Clin Pharmacol       Date:  2010-10-26

Review 4.  Barriers in the quest for quality drug information: salutary lessons from TGA-approved sources for thyroid-related medications.

Authors:  Jim R Stockigt
Journal:  Med J Aust       Date:  2007-01-15       Impact factor: 7.738

5.  Advice on drug safety in pregnancy: are there differences between commonly used sources of information?

Authors:  Sofia K Frost Widnes; Jan Schjøtt
Journal:  Drug Saf       Date:  2008       Impact factor: 5.606

6.  Obstetrician-gynaecologist knowledge of and access to information about the risks of medication use during pregnancy.

Authors:  Maria A Morgan; Janet D Cragan; Robert L Goldenberg; Sonja A Rasmussen; Jay Schulkin
Journal:  J Matern Fetal Neonatal Med       Date:  2010-10

7.  Views of obstetric practitioners and hospital pharmacists on therapeutic goods administration approved product information for pregnancy and lactation.

Authors:  Emma Brown; Elizabeth Hotham; Neil Hotham
Journal:  Aust N Z J Obstet Gynaecol       Date:  2014-02-25       Impact factor: 2.100

8.  Choice of breastfeeding and physicians' advice: a cohort study of women receiving propylthiouracil.

Authors:  A Lee; M E Moretti; A Collantes; D Chong; P Mazzotta; G Koren; S S Merchant; S Ito
Journal:  Pediatrics       Date:  2000-07       Impact factor: 7.124

9.  Lactation safety recommendations and reliability compared in 10 medication resources.

Authors:  Monica Akus; Melissa Bartick
Journal:  Ann Pharmacother       Date:  2007-07-10       Impact factor: 3.154

10.  Depression during pregnancy: views on antidepressant use and information sources of general practitioners and pharmacists.

Authors:  Tessa Ververs; Liset van Dijk; Somaye Yousofi; Fred Schobben; Gerard H A Visser
Journal:  BMC Health Serv Res       Date:  2009-07-17       Impact factor: 2.655

View more
  4 in total

1.  Information Needs and Counseling Preferences among Potential Users of the Future Teratology Information Service in Belgium: A Cross-Sectional Study Involving the Public and Healthcare Professionals.

Authors:  Michael Ceulemans; Kristel Van Calsteren; Karel Allegaert; Veerle Foulon
Journal:  Int J Environ Res Public Health       Date:  2022-07-14       Impact factor: 4.614

2.  A descriptive analysis of calls to the NSW Teratogen Information Service regarding use of anti-infectives during pregnancy.

Authors:  Helen E Ritchie; Elizabeth Hegedus; Joanne Ma; Debra Kennedy
Journal:  PLoS One       Date:  2022-10-06       Impact factor: 3.752

3.  Medications and pregnancy: The role of community pharmacists - A descriptive study.

Authors:  Hoi Ying Leung; Bandana Saini; Helen E Ritchie
Journal:  PLoS One       Date:  2018-05-09       Impact factor: 3.240

4.  SafeMotherMedicine: Aiming to Increase Women's Empowerment in Use of Medications During Pregnancy and Breastfeeding.

Authors:  Kristine Heitmann; Jan Schjøtt
Journal:  Matern Child Health J       Date:  2020-05
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.